Clofibric acid

CAS No. 882-09-7

Clofibric acid( NSC 1149 )

Catalog No. M16397 CAS No. 882-09-7

Clofibric acid is a PPARα agonist and hypolipidemic agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 30 In Stock
100MG 42 In Stock
200MG 61 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Clofibric acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Clofibric acid is a PPARα agonist and hypolipidemic agent.
  • Description
    Clofibric acid is a PPARα agonist and hypolipidemic agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC 1149
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPAR
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    882-09-7
  • Formula Weight
    214.65
  • Molecular Formula
    C10H11ClO3
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 43 mg/mL (200.32 mM); DMSO: 43 mg/mL (200.32 mM)
  • SMILES
    CC(C)(OC1=CC=C(Cl)C=C1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Richert L, et al. Toxicol Appl Pharmacol, 2003, 191(2), 130-146.
molnova catalog
related products
  • GW590735

    GW590735 is an effective and selective PPARα agonist with an EC50 of 4 nM on PPARα and at least 500-fold selectivity versus PPARδ and PPARγ. GW590735 can be used in dyslipidemia studies.

  • DG172 (dihydrochlori...

    DG172 (dihydrochloride) is an ?antagonist of ?PPARβ/δ(IC50 : 27 nM).

  • Mifobate

    Mifobate is a potent and specific antagonist of PPARγ. Mifobate shows antiobesity, antidiabetic and antiatherosclerotic effects.